Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07211997) titled 'FebriDx(R) Pediatric Validation Study' on Oct. 1.
Study Type: Observational
Primary Sponsor: Lumos Diagnostics
Condition:
Acute Respiratory Infections (ARIs)
Intervention:
Device: FebriDx
Recruitment Status: Not recruiting
Date of First Enrollment: October 15, 2025
Target Sample Size: 800
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07211997
Published by HT Digital Content Services with permission from Health Daily Digest....